129 related articles for article (PubMed ID: 35256856)
41. Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma.
Machens A; Holzhausen HJ; Lautenschläger C; Thanh PN; Dralle H
Cancer; 2003 Aug; 98(4):712-9. PubMed ID: 12910514
[TBL] [Abstract][Full Text] [Related]
42. Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients.
Zhang L; Wei WJ; Ji QH; Zhu YX; Wang ZY; Wang Y; Huang CP; Shen Q; Li DS; Wu Y
J Clin Endocrinol Metab; 2012 Apr; 97(4):1250-7. PubMed ID: 22319042
[TBL] [Abstract][Full Text] [Related]
43. The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study.
Rozenblat T; Hirsch D; Robenshtok E; Grozinsky-Glasberg S; Gross DJ; Mazeh H; Benbassat C; Twito O; Levy S; Mizrachi A; Shpitzer T; Bachar G
Eur J Surg Oncol; 2020 Nov; 46(11):2023-2028. PubMed ID: 32389525
[TBL] [Abstract][Full Text] [Related]
44. Metastatic Risk Stratification of 2526 Medullary Thyroid Carcinoma Patients: A Study Based on Surveillance, Epidemiology, and End Results Database.
Le MK; Kawai M; Odate T; Vuong HG; Oishi N; Kondo T
Endocr Pathol; 2022 Sep; 33(3):348-358. PubMed ID: 35852678
[TBL] [Abstract][Full Text] [Related]
45. Machine Learning for Predicting Distant Metastasis of Medullary Thyroid Carcinoma Using the SEER Database.
Guo ZT; Tian K; Xie XY; Zhang YH; Fang DB
Int J Endocrinol; 2023; 2023():9965578. PubMed ID: 38186857
[TBL] [Abstract][Full Text] [Related]
46. Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma.
Luo Y; Zhao Y; Chen K; Shen J; Shi J; Lu S; Lei J; Li Z; Luo D
J Endocrinol Invest; 2019 Feb; 42(2):227-236. PubMed ID: 29876836
[TBL] [Abstract][Full Text] [Related]
47. A Specific Predicting Model for Screening Skip Metastasis From Patients With Negative Central Lymph Nodes Metastasis in Papillary Thyroid Cancer.
Yang Z; Heng Y; Zhao Q; Cao Z; Tao L; Qiu W; Cai W
Front Endocrinol (Lausanne); 2021; 12():743900. PubMed ID: 34659126
[TBL] [Abstract][Full Text] [Related]
48. Indications and oncological outcomes of selective dissection for clinically suspected lateral lymph node metastasis in patients with rectal cancer based on pretreatment imaging.
Yang X; Gu C; Hu T; Wei M; Meng W; Wang Z; Deng X; Zhou Z
Tech Coloproctol; 2021 Apr; 25(4):425-437. PubMed ID: 33585985
[TBL] [Abstract][Full Text] [Related]
49. Superior Located Papillary Thyroid Microcarcinoma is a Risk Factor for Lateral Lymph Node Metastasis.
Back K; Kim JS; Kim JH; Choe JH
Ann Surg Oncol; 2019 Nov; 26(12):3992-4001. PubMed ID: 31264121
[TBL] [Abstract][Full Text] [Related]
50. The analysis of clinicopathologic predictors of lymph node metastasis and postoperative recurrence in patients with papillary thyroid microcarcinoma from Guangdong Province, China-a multicenter retrospective study.
He LY; Chen ML; Wang WW; Balde AI; Li Z; Cai Z; Han S; Lei ST; Zhou MW; Zhang GQ
Int J Clin Exp Pathol; 2017; 10(9):9735-9743. PubMed ID: 31966856
[TBL] [Abstract][Full Text] [Related]
51. Capsular extension at ultrasound is associated with lateral lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study.
Ye L; Hu L; Liu W; Luo Y; Li Z; Ding Z; Hu C; Wang L; Zhu Y; Liu L; Ma X; Kong Y; Huang L
BMC Cancer; 2021 Nov; 21(1):1250. PubMed ID: 34800991
[TBL] [Abstract][Full Text] [Related]
52. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
53. Clinicopathological Profile of Medullary Thyroid Carcinoma-Could We Predict Aggressive Behavior?
Giusca SE; Andriescu EC; Caruntu ID; Ciobanu D
Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672624
[TBL] [Abstract][Full Text] [Related]
54. Does shear wave elastography for medullary thyroid carcinoma predict lateral cervical lymph node metastasis?
Wen X; Li B; Yu X; Huang Y; Cheng W; Su Z
Eur J Radiol; 2022 Jan; 146():110079. PubMed ID: 34864615
[TBL] [Abstract][Full Text] [Related]
55. Management of synchronous lateral pelvic nodal metastasis in rectal cancer in the era of neoadjuvant chemoradiation: A systemic review.
Wong JSM; Tan GHC; Chia CS; Ong CJ; Teo MCC
World J Gastrointest Surg; 2020 May; 12(5):247-258. PubMed ID: 32551030
[TBL] [Abstract][Full Text] [Related]
56. [Risk Factors of Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma:An Analysis Based on Data from the Surveillance, Epidemiology and End Results Database].
Zheng KS; Zeng Y; Chen C; Wu YZ; Chen B; Ying WB; Zheng KW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Dec; 40(6):736-743. PubMed ID: 30606382
[TBL] [Abstract][Full Text] [Related]
57. Lateral lymph node metastasis in papillary thyroid carcinoma: A systematic review and meta-analysis for prevalence, risk factors, and location.
So YK; Kim MJ; Kim S; Son YI
Int J Surg; 2018 Feb; 50():94-103. PubMed ID: 29329789
[TBL] [Abstract][Full Text] [Related]
58. Risk factors for right paraesophageal lymph node metastasis in papillary thyroid carcinoma: A meta-analysis.
Shao L; Sun W; Zhang H; Zhang P; Wang Z; Dong W; He L; Zhang T; Qin Y
Surg Oncol; 2020 Mar; 32():90-98. PubMed ID: 31987575
[TBL] [Abstract][Full Text] [Related]
59. Risk Factors for Central and Lateral Lymph Node Metastases in Patients With Papillary Thyroid Micro-Carcinoma: Retrospective Analysis on 484 Cases.
Huang Y; Yin Y; Zhou W
Front Endocrinol (Lausanne); 2021; 12():640565. PubMed ID: 33746905
[TBL] [Abstract][Full Text] [Related]
60. Nomograms to predict ipsilateral and contralateral central lymph node metastasis in clinically lymph node-negative patients with solitary isthmic classic papillary thyroid carcinoma.
Feng JW; Qu Z; Ye J; Hong LZ; Liu SY; Wang F; Jiang Y; Hu J
Surgery; 2021 Dec; 170(6):1670-1679. PubMed ID: 34275617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
